Recent News

• 09.11.2025 - Athira Pharma Announces Reverse Stock Split
• 09.11.2025 - Athira Pharma Announces Reverse Stock Split
• 08.14.2025 - Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025
• 08.14.2025 - Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025
• 08.07.2025 - Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.07.2025 - Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update

Recent Filings

• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.07.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 8-K Current report
• 07.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.01.2025 - 144 Report of proposed sale of securities
• 07.01.2025 - 144 Report of proposed sale of securities